Global Diabetic Foot Ulcers and Pressure Ulcers Market – Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2016-2021 and Forecast 2022-2028

$ PRICE - $ 3,000.00$ 8,900.00

Diabetic Foot Ulcers and Pressure Ulcers Market: By Disease Type (Diabetic Foot Ulcers, Pressure Ulcers), By Treatment (Wound Care Dressings, Bio-actives, Wound Care Devices), By End User (Hospitals, Clinics, Home Healthcare, Community Health Centers, Others), and Geography

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail

Report

Description

Diabetic Foot Ulcers And Pressure Ulcers Market size was valued at 4,609.2 million in 2021 and is expected to reach 7,747.0 million by 2028, at a CAGR of 7.7% during the forecast period 2022 to 2028. Diabetic foot ulcers are the full-thickness wounds present below the ankle in diabetic patients. The risk factors for the diabetic foot ulcers include poor blood circulation, neuropathy, and insufficiently well controlled diabetes are among others. Pressure ulcers or bedsores are injuries to skin and underlying tissue, caused by the prolonged pressure on skin. Pressure ulcers are majorly affect the persons with paralysis, old age, illness, and frailty.

Diabetic Foot Ulcers And Pressure Ulcers Market

MARKET SUMMARY
-
7.7%
  • Study Period– 2022 – 2028
  • Base Year– 2021
  • CAGR– 7.7%
  • Largest Market– Asia-Pacific
  • Fastest Growing Market– North-America

Diabetic Foot Ulcers And Pressure Ulcers Market

  • The global diabetic foot ulcers and pressure ulcers market report gives comprehensive outlook across the globe with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa.
  • The report on global market gives historical, current, and future market sizes (US$ Mn) on the basis of disease type, by treatment, end user and region.
Key Players
  • Medtronic plc
  • Braun Melsungen AG
  • Smith & Nephew plc
  • CovaTec, Inc.
  • Coloplast A/S
  • Organogenesis, Inc.
Diabetic Foot Ulcers And Pressure Ulcers Market

DRIVERS AND RESTRAINTS

Increase in the prevalence diabetes and neuropathic diseases such as paralysis surge the global diabetic foot ulcers and pressure ulcers market. Moreover, rise in R&D expenditure for the innovation of newer therapeutics, government initiations to control the diabetes and chronic wounds, grow in incidence of paralysis and other chronic diseases reduces the mobility, unhealthy lifestyle, and increase in geriatric population are anticipated to propel the diabetic foot ulcers and pressure ulcers market over the forecast years. However, high cost of treatment, dearth of skilled professionals in underdeveloped countries, and limited number of biologicals for the treatment are restrain the growth of global market.


North-America Got Significant Share

Diabetic Foot Ulcers And Pressure Ulcers Market

Geographically, global market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America market has a lucrative growth attributed to rise in prevalence of diabetic foot ulcers and pressure ulcers due to increase in the incidence of diabetes, advancements in the treatment procedures, and increase in healthcare expenditure are bolster the market. Europe market is poised to grow attributed to increase in the prevalence of diabetes and neurological disorders, high adoption of newer treatment procedures, and rise in disposable income are fuel the market. Asia Pacific market has prominent share attributed to rise in geriatric population in India, China, and Japan, large patient pool, and entry of market players into Asia Pacific region are bolster the market.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Developments

  • In January 2019, FDA approved Integra Omnigraft Dermal Regeneration Matrix to treat disabetic foot ulcers
Diabetic Foot Ulcers And Pressure Ulcers Market Segmentation


Location

GEOGRAPHY

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.


Report

Table Of Content


Report

Company Profile

  • Medtronic plc (Ireland)
  • Braun Melsungen AG (Germany)
  • Smith & Nephew plc (U.K.)
  • CovaTec, Inc. (U.S.)
  • Coloplast A/S (Denmark)
  • Organogenesis, Inc. (U.S.)
  • Medline Industries, Inc. (U.S.)
  • 3M Healthcare (U.S.)
  • BSN Medical GmbH (Hamburg)
  • Integra Life Sciences Corporation (U.S.)
  • Molnlycke Health Care AB (Sweden)

Description

Diabetic Foot Ulcers And Pressure Ulcers Market size was valued at 4,609.2 million in 2021 and is expected to reach 7,747.0 million by 2028, at a CAGR of 7.7% during the forecast period 2022 to 2028. Diabetic foot ulcers are the full-thickness wounds present below the ankle in diabetic patients. The risk factors for the diabetic foot ulcers include poor blood circulation, neuropathy, and insufficiently well controlled diabetes are among others. Pressure ulcers or bedsores are injuries to skin and underlying tissue, caused by the prolonged pressure on skin. Pressure ulcers are majorly affect the persons with paralysis, old age, illness, and frailty.

ASIA PACIFIC OFFICE

Precision Business Insights, MIG 366, SAI PLAZA, 1st Floor, KPHB Colony, Hyderabad - 500072

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX